Temporal and Spatial Evolution of Somatic Chromosomal Alterations: A Case-Cohort Study of Barrett's Esophagus

All cancers are believed to arise by dynamic, stochastic somatic genomic evolution with genome instability, generation of diversity, and selection of genomic alterations that underlie multistage progression to cancer. Advanced esophageal adenocarcinomas have high levels of somatic copy number alterations. Barrett's esophagus is a risk factor for developing esophageal adenocarcinoma, and somatic chromosomal alterations (SCA) are known to occur in Barrett's esophagus. The vast majority (∼95%) of individuals with Barrett's esophagus do not progress to esophageal adenocarcinoma during their lifetimes, but a small subset develop esophageal adenocarcinoma, many of which arise rapidly even in carefully monitored patients without visible endoscopic abnormalities at the index endoscopy. Using a well-designed, longitudinal case-cohort study, we characterized SCA as assessed by single-nucleotide polymorphism arrays over space and time in 79 “progressors” with Barrett's esophagus as they approach the diagnosis of cancer and 169 “nonprogressors” with Barrett's esophagus who did not progress to esophageal adenocarcinoma over more than 20,425 person-months of follow-up. The genomes of nonprogressors typically had small localized deletions involving fragile sites and 9p loss/copy neutral LOH that generate little genetic diversity and remained relatively stable over prolonged follow-up. As progressors approach the diagnosis of cancer, their genomes developed chromosome instability with initial gains and losses, genomic diversity, and selection of SCAs followed by catastrophic genome doublings. Our results support a model of differential disease dynamics in which nonprogressor genomes largely remain stable over prolonged periods, whereas progressor genomes evolve significantly increased SCA and diversity within four years of esophageal adenocarcinoma diagnosis, suggesting a window of opportunity for early detection. Cancer Prev Res; 7(1); 114–27. ©2013 AACR.

[1]  Steven J. M. Jones,et al.  Circos: an information aesthetic for comparative genomics. , 2009, Genome research.

[2]  M. Feith,et al.  Temporal Trends in Long-Term Survival and Cure Rates in Esophageal Cancer: A SEER Database Analysis , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[3]  N. Seersholm,et al.  Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study , 1999, American Journal of Gastroenterology.

[4]  Derek Y. Chiang,et al.  The landscape of somatic copy-number alteration across human cancers , 2010, Nature.

[5]  J. Salk Clonal evolution in cancer , 2010 .

[6]  K. Gunderson,et al.  Deletion at Fragile Sites Is a Common and Early Event in Barrett's Esophagus , 2010, Molecular Cancer Research.

[7]  Gary Longton,et al.  Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets , 2000, American Journal of Gastroenterology.

[8]  Kamran Ayub,et al.  NSAIDs Modulate CDKN2A, TP53, and DNA Content Risk for Progression to Esophageal Adenocarcinoma , 2007, PLoS medicine.

[9]  O. Yokosuka,et al.  Abstract 4383: Targeting tumor microenvironment with gemcitabine is useful for the treatment of pancreatic ductal adenocarcinoma , 2012 .

[10]  A. McKenna,et al.  Exome and whole genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity , 2013, Nature Genetics.

[11]  K. Kinzler,et al.  Genetic instabilities in human cancers , 1998, Nature.

[12]  N. Pavelka,et al.  Dr Jekyll and Mr Hyde: role of aneuploidy in cellular adaptation and cancer. , 2010, Current opinion in cell biology.

[13]  Xiaohong Li,et al.  Direct Inference of SNP Heterozygosity Rates and Resolution of LOH Detection , 2007, PLoS Comput. Biol..

[14]  H. Welch,et al.  Overdiagnosis in cancer. , 2010, Journal of the National Cancer Institute.

[15]  Sonika Tyagi,et al.  Whole Genome Expression Array Profiling Highlights Differences in Mucosal Defense Genes in Barrett's Esophagus and Esophageal Adenocarcinoma , 2011, PloS one.

[16]  Carissa A. Sanchez,et al.  Genetic clonal diversity predicts progression to esophageal adenocarcinoma , 2006, Nature Genetics.

[17]  J. Marioni,et al.  Integrative analysis of array-comparative genomic hybridisation and matched gene expression profiling data reveals novel genes with prognostic significance in oesophageal adenocarcinoma , 2011, Gut.

[18]  Steven G. Self,et al.  Asymptotic Distribution Theory and Efficiency Results for Case-Cohort Studies , 1988 .

[19]  J. Goldblum,et al.  Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. , 1998, The Annals of thoracic surgery.

[20]  Yuchen Jiao,et al.  Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. , 2012, Cancer discovery.

[21]  A. Sivachenko,et al.  Punctuated Evolution of Prostate Cancer Genomes , 2013, Cell.

[22]  J. Goldblum,et al.  Intramucosal esophageal adenocarcinoma: primum non nocere. , 2013, The Journal of thoracic and cardiovascular surgery.

[23]  A. Sonnenberg,et al.  Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma , 2002, American Journal of Gastroenterology.

[24]  Brian J. Reid,et al.  Safety of a systematic endoscopic biopsy protocol in patients with Barrett’s esophagus , 2000 .

[25]  R. L. Prentice,et al.  A case-cohort design for epidemiologic cohort studies and disease prevention trials , 1986 .

[26]  G. Tytgat,et al.  Impact of endoscopic biopsy surveillance of Barrett’s oesophagus on pathological stage and clinical outcome of Barrett’s carcinoma , 1998, Gut.

[27]  Brian Reid,et al.  Overdiagnosis and overtreatment in cancer: an opportunity for improvement. , 2013, JAMA.

[28]  Wei Zhao,et al.  Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas. , 2013, Gastroenterology.

[29]  Patricia L. Blount,et al.  Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia , 2000, American Journal of Gastroenterology.

[30]  A. Sonnenberg,et al.  Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. , 2001, Gastroenterology.

[31]  A. Wicks,et al.  Ten years’ experience of screening patients with Barrett’s oesophagus in a university teaching hospital , 1997, Gut.

[32]  B. Reid,et al.  Progression to cancer in Barrett's esophagus is associated with genomic instability. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[33]  Xiaohong Li,et al.  Application of Biomarkers in Cancer Risk Management: Evaluation from Stochastic Clonal Evolutionary and Dynamic System Optimization Points of View , 2011, PLoS Comput. Biol..

[34]  Prateek Sharma,et al.  Long-term follow-up of Barrett's high-grade dysplasia , 2000, American Journal of Gastroenterology.

[35]  F. Markowetz,et al.  The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.

[36]  A. McKenna,et al.  Absolute quantification of somatic DNA alterations in human cancer , 2012, Nature Biotechnology.

[37]  Carissa A. Sanchez,et al.  Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study. , 2005, The Lancet. Oncology.

[38]  Carissa A. Sanchez,et al.  Evolution of neoplastic cell lineages in Barrett oesophagus , 1999, Nature Genetics.

[39]  N. Hayward,et al.  Genome-wide copy number analysis in esophageal adenocarcinoma using high-density single-nucleotide polymorphism arrays. , 2008, Cancer research.

[40]  Noel S Weiss,et al.  Surveillance and survival in Barrett's adenocarcinomas: a population-based study. , 2002, Gastroenterology.

[41]  B. Reid,et al.  Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis , 2010, Nature Reviews Cancer.

[42]  M. Meyerson,et al.  Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. , 2012, Cancer research.

[43]  Patricia L. Blount,et al.  Single Nucleotide Polymorphism–Based Genome-Wide Chromosome Copy Change, Loss of Heterozygosity, and Aneuploidy in Barrett's Esophagus Neoplastic Progression , 2008, Cancer Prevention Research.

[44]  J. Troge,et al.  Tumour evolution inferred by single-cell sequencing , 2011, Nature.

[45]  J. Troge,et al.  Inferring tumor progression from genomic heterogeneity. , 2010, Genome research.

[46]  J. Reguła,et al.  Molecular defense mechanisms of Barrett’s metaplasia estimated by an integrative genomics , 2007, Journal of Molecular Medicine.

[47]  N. Carter,et al.  Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development , 2011, Cell.

[48]  David F Ransohoff,et al.  Principles of cancer screening: lessons from history and study design issues. , 2010, Seminars in oncology.

[49]  Xiaohong Li,et al.  A Comprehensive Survey of Clonal Diversity Measures in Barrett's Esophagus as Biomarkers of Progression to Esophageal Adenocarcinoma , 2010, Cancer Prevention Research.

[50]  Patricia L. Blount,et al.  Safety of a systematic endoscopic biopsy protocol in patients with Barrett's esophagus , 2000, American Journal of Gastroenterology.

[51]  Patrick O. Brown,et al.  The Preclinical Natural History of Serous Ovarian Cancer: Defining the Target for Early Detection , 2009, PLoS medicine.

[52]  H. Welch,et al.  The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. , 2005, Journal of the National Cancer Institute.

[53]  H. Sørensen,et al.  Incidence of adenocarcinoma among patients with Barrett's esophagus. , 2011, The New England journal of medicine.

[54]  B. Reid,et al.  p53-mutant clones and field effects in Barrett's esophagus. , 1999, Cancer research.

[55]  Martin A. Nowak,et al.  The significance of unstable chromosomes in colorectal cancer , 2003, Nature Reviews Cancer.

[56]  M. Nowak,et al.  Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer , 2010, Nature.

[57]  E. Kuipers,et al.  Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[58]  Kenneth K Wang,et al.  Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus , 1998, The American Journal of Gastroenterology.

[59]  L. Cavalli-Sforza,et al.  Multilocus genotypes, a tree of individuals, and human evolutionary history. , 1997, American journal of human genetics.

[60]  Carissa A. Sanchez,et al.  17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[61]  Kenneth K Wang,et al.  Genome-Wide Catalogue of Chromosomal Aberrations in Barrett's Esophagus and Esophageal Adenocarcinoma: A High-Density Single Nucleotide Polymorphism Array Analysis , 2010, Cancer Prevention Research.

[62]  R. Odze What the gastroenterologist needs to know about the histology of Barrett's esophagus , 2011, Current opinion in gastroenterology.

[63]  C. Gutschow,et al.  Prognostic impact of nodal micrometastasis in early esophageal cancer. , 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[64]  David Pellman,et al.  Causes and consequences of aneuploidy in cancer , 2012, Nature Reviews Genetics.

[65]  Martin A. Nowak,et al.  Comparative lesion sequencing provides insights into tumor evolution , 2008, Proceedings of the National Academy of Sciences.

[66]  Prateek Sharma,et al.  American Gastroenterological Association medical position statement on the management of Barrett's esophagus. , 2011, Gastroenterology.